Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro dose is 0.5 ml, regardless of which strength you're injecting. Whether the pen contains 2.5 mg or 15 mg of tirzepatide, the liquid volume delivered under the skin stays the same — a fact that surprises many people who assume a higher dose must mean a larger injection. As a prescription-only medicine, Mounjaro is only available following clinical assessment by a registered prescriber, who decides which strength is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes. All six Mounjaro strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg) are injected as a fixed 0.5 ml dose. Eli Lilly achieves the different strengths by varying the concentration of tirzepatide in the solution, not by changing how much liquid is injected. So if you move from 5 mg to 7.5 mg, you won't notice any difference in how the injection feels, the volume is identical.
This matters practically. Some people worry that higher doses will involve a noticeably larger injection. They don't. The needle length, the pen mechanism, and the sensation at the injection site are consistent throughout the treatment schedule. What changes is the pharmacological effect, not the physical experience of injecting. For a detailed look at exactly how many mls the 2.5 mg Mounjaro pen contains, this breaks it down further, and if you want to understand that starting dose in even more granular terms, this page walking through how many mls are in the 2.5 mg Mounjaro dose covers it from a slightly different angle.
The NHS tirzepatide patient information page explains the standard once-weekly injection routine in plain language and is worth reading alongside the Patient Information Leaflet that comes in the box.
The Mounjaro KwikPen is a multi-dose, pre-filled device. Each pen contains four weekly doses, meaning the total cartridge holds 2 ml of solution (4 × 0.5 ml). You don't draw up the liquid or measure anything, the pen doses automatically. Pressing the button to the end completes one 0.5 ml injection. That's it.
Because the pen is pre-set, there is no way to accidentally inject more or less than 0.5 ml. This is a deliberate safety feature. The pen also locks after the fourth injection, preventing an accidental fifth use from an empty cartridge. If you're curious about how doses are spaced across a pen's lifespan, the page on how many doses a Mounjaro pen holds covers the practical details clearly.
One pen covers a four-week period at any single strength. At the point a prescriber increases your dose, you move to a pen of the new strength, the mechanism and volume experience remain unchanged. For context on what the 5 mg pen specifically involves, the 5 mg Mounjaro page has the relevant detail.
Not meaningfully. Mounjaro is injected subcutaneously (into the fatty layer just beneath the skin) in the abdomen, thigh, or upper arm. At 0.5 ml, the volume is small enough that site selection is driven by comfort and rotation, not by the amount of liquid. Rotating sites each week reduces the chance of skin reactions at any one spot.
The pen itself arrives by tracked next-working-day delivery in plain, unbranded packaging, most people keep it in the fridge door and bring it to room temperature for a few minutes before injecting, which can reduce the chance of a sting. Always consult the Patient Information Leaflet for the exact storage window and preparation steps; the permitted time out of refrigeration varies and the leaflet is the authoritative source for those specifics.
For anyone wondering about the broader picture of dose volumes across different presentations, this related page on Mounjaro dose volumes addresses the question from a slightly different angle. Our clinical team's approach to prescribing and aftercare is described on the clinical team page if you'd like to know more about who reviews consultations.
Different Mounjaro strengths are priced differently in the private market. Following Eli Lilly's UK list-price revision in September 2025 (widely reported at the time) private monthly prices across providers typically range from around £149 to £375, depending on dose and supplier. The higher the strength, the higher the list price tends to be. For a clearer picture of what's involved, the Mounjaro cost page lays out what legitimate private pricing includes and what it often doesn't.
At nume, the price you see covers the consultation, the prescription, the treatment itself, and free next-working-day delivery, no subscriptions, no hidden fees. A named prescriber, not software, reads your answers before anything is approved or dispatched. That clinical review happens the same day for orders placed before 12 pm. If you'd like to explore treatment options, starting with a free consultation is the right first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.